Hims & Hers Health (HIMS) Short Interest Ratio & Short Volume

Hims & Hers Health logo
$42.52 +2.05 (+5.07%)
Closing price 02/7/2025 03:59 PM Eastern
Extended Trading
$42.56 +0.03 (+0.08%)
As of 02/7/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Hims & Hers Health Short Interest Data

Hims & Hers Health (HIMS) has a short interest of 56.58 million shares, representing 31.87% of the float (the number of shares available for trading by the public). This marks a 8.56% increase in short interest from the previous month. The short interest ratio (days to cover) is 3.6, indicating that it would take 3.6 days of the average trading volume of 11.48 million shares to cover all short positions.

Current Short Interest
56,580,000 shares
Previous Short Interest
52,120,000 shares
Change Vs. Previous Month
+8.56%
Dollar Volume Sold Short
$1.57 billion
Short Interest Ratio
3.6 Days to Cover
Last Record Date
January 15, 2025
Outstanding Shares
218,479,000 shares
Float Size
177,520,000 shares
Short Percent of Float
31.87%
Today's Trading Volume
21,811,816 shares
Average Trading Volume
11,475,684 shares
Today's Volume Vs. Average
190%
Short Selling Hims & Hers Health?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Hims & Hers Health and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

HIMS Short Interest Over Time

HIMS Days to Cover Over Time

HIMS Percentage of Float Shorted Over Time

Hims & Hers Health Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/15/202556,580,000 shares $1.57 billion +8.6%31.9%3.6 $27.81
12/31/202452,120,000 shares $1.26 billion +21.3%29.4%3.2 $24.18
12/15/202442,970,000 shares $1.29 billion +0.8%24.2%2.6 $30.02
11/30/202442,620,000 shares $1.37 billion +7.8%24.0%2.7 $32.22
11/15/202439,520,000 shares $765.11 million +16.8%22.3%2.7 $19.36
10/31/202433,840,000 shares $637.71 million +6.2%19.1%3.1 $18.85
10/15/202431,870,000 shares $726.64 million +28.7%18.3%3.2 $22.80
9/30/202424,760,000 shares $456.20 million -6.7%14.2%2.6 $18.43
9/15/202426,540,000 shares $439.77 million -5.4%16.2%3 $16.57
8/31/202428,040,000 shares $413.03 million +21.7%17.1%3 $14.73
8/15/202423,040,000 shares $362.07 million +19.6%14.0%2.2 $15.72
7/31/202419,260,000 shares $409.08 million -2.8%12.7%1.6 $21.24
7/15/202419,810,000 shares $452.46 million +12.8%13.1%1.9 $22.84
6/30/202417,560,000 shares $354.54 million +3.3%11.7%1.7 $20.19
6/15/202417,000,000 shares $403.75 million -19.7%11.3%1.8 $23.75
5/31/202421,160,000 shares $410.93 million -4.4%14.0%2.5 $19.42
5/15/202422,130,000 shares $305.62 million +20.3%14.7%2.7 $13.81
4/30/202418,390,000 shares $230.24 million +5.3%13.2%3 $12.52
4/15/202417,470,000 shares $230.95 million +34.6%12.5%3.5 $13.22
3/31/202412,980,000 shares $200.80 million +1.7%9.4%2.8 $15.47
3/15/202412,760,000 shares $186.81 million +0.9%9.2%2.9 $14.64
2/29/202412,650,000 shares $164.96 million -6.1%9.1%3.1 $13.04
2/15/202413,470,000 shares $135.37 million -6.6%10.0%4.1 $10.05
1/31/202414,420,000 shares $123.72 million -5.2%10.6%4.8 $8.58
1/15/202415,210,000 shares $130.35 million +1.1%11.2%5.3 $8.57
12/31/202315,040,000 shares $133.86 million -4.0%11.1%5.3 $8.90
12/15/202315,670,000 shares $132.33 million -7.9%11.5%6 $8.45
11/30/202317,020,000 shares $151.31 million -1.7%12.5%6.7 $8.89
11/15/202317,310,000 shares $133.63 million +2.1%12.8%7.2 $7.72
10/31/202316,960,000 shares $101.42 million -0.9%12.6%6.9 $5.98
10/15/202317,120,000 shares $107 million -3.0%12.7%6.7 $6.25
9/30/202317,640,000 shares $110.96 million +5.4%13.1%6.5 $6.29
9/15/202316,730,000 shares $105.57 million +0.5%12.4%5.9 $6.31
8/31/202316,650,000 shares $111.72 million -5.8%12.4%5.6 $6.71
8/15/202317,680,000 shares $127.03 million -21.4%13.1%5.4 $7.19
7/31/202322,480,000 shares $201.53 million -8.2%16.9%6.5 $8.97
7/15/202324,490,000 shares $216.98 million +10.9%18.4%7.7 $8.86
6/30/202322,090,000 shares $207.65 million +4.8%16.6%6.5 $9.40
6/15/202321,080,000 shares $185.50 million +3.9%15.8%6.2 $8.80
5/31/202320,280,000 shares $181.30 million -3.2%15.3%5.8 $8.94
Elon’s AI venture could 10X (here’s how you could profit) (Ad)

What does Elon plan with all this computing power? Our research indicates he's gunning to take over the entire AI industry - which is projected to grow up to $23 TRILLION annually in the coming years... Elon's AI venture is already growing 7X faster than its main competitor, OpenAI. It could soon be the most powerful AI firm on the planet.

5/15/202320,940,000 shares $225.52 million -7.0%17.0%5.4 $10.77
4/30/202322,510,000 shares $260.89 million -2.0%18.4%6.1 $11.59
4/15/202322,960,000 shares $224.09 million +2.5%18.9%6.7 $9.76
3/31/202322,410,000 shares $222.31 million +7.1%18.5%7.6 $9.92
3/15/202320,930,000 shares $188.58 million +9.8%17.3%8 $9.01
2/28/202319,060,000 shares $214.81 million +5.8%15.8%8.2 $11.27
2/15/202318,010,000 shares $180.64 million +4.4%15.9%10.5 $10.03
1/31/202317,260,000 shares $142.91 million +5.2%16.2%9.1 $8.28
1/15/202316,400,000 shares $123.49 million +1.5%15.4%9.5 $7.53
12/30/202216,160,000 shares $103.59 million No Change15.2%9.2 $6.41
12/15/202216,160,000 shares $111.50 million -1.8%15.2%9.2 $6.90
11/30/202216,460,000 shares $101.89 million +3.1%15.5%9.5 $6.19
11/15/202215,970,000 shares $98.85 million +21.2%15.1%9.4 $6.19
10/31/202213,180,000 shares $59.84 million -5.4%12.5%8.1 $4.54
10/15/202213,930,000 shares $66.45 million +6.5%13.2%8.9 $4.77
9/30/202213,080,000 shares $72.99 million -4.1%12.4%8.3 $5.58
9/15/202213,640,000 shares $82.25 million +2.3%12.9%7.1 $6.03
8/31/202213,340,000 shares $84.84 million +0.7%12.7%6.5 $6.36
8/15/202213,250,000 shares $95.67 million +6.6%12.6%6.3 $7.22
7/31/202212,430,000 shares $76.94 million +1.0%12.1%5.3 $6.19
7/15/202212,310,000 shares $67.83 million +4.4%12.0%5.4 $5.51
6/30/202211,790,000 shares $53.41 million +27.1%11.5%5.1 $4.53
6/15/20229,280,000 shares $37.77 million +3.3%9.1%4.1 $4.07
5/31/20228,980,000 shares $36.28 million -7.6%8.8%4.2 $4.04
5/15/20229,720,000 shares $33.53 million +12.0%9.5%4 $3.45
4/30/20228,680,000 shares $36.54 million +7.8%7.9%4 $4.21
4/15/20228,050,000 shares $40.73 million -1.8%7.3%3.5 $5.06
3/31/20228,200,000 shares $43.71 million -8.1%7.5%3.5 $5.33
3/15/20228,920,000 shares $38.71 million -13.8%8.1%3.7 $4.34
2/28/202210,350,000 shares $54.03 million +5.5%9.4%4.3 $5.22
2/15/20229,810,000 shares $47.77 million +20.2%8.9%4 $4.87
1/31/20228,160,000 shares $39.82 million +5.2%8.4%3.1 $4.88
1/15/20227,760,000 shares $41.05 million -11.2%8.0%3 $5.29
12/31/20218,740,000 shares $57.25 million -7.3%9.0%3.5 $6.55
12/15/20219,430,000 shares $59.88 million -2.3%9.7%3.8 $6.35
11/30/20219,650,000 shares $63.21 million +14.7%10.0%4 $6.55
11/15/20218,410,000 shares $68.71 million +23.5%7.9%3.4 $8.17
10/29/20216,810,000 shares $53.12 million +10.0%8.8%2.8 $7.80
10/15/20216,190,000 shares $51.75 million -3.4%8.0%2.4 $8.36
9/30/20216,410,000 shares $48.33 million +13.1%8.3%2.5 $7.54
9/15/20215,670,000 shares $49.10 million +2.0%7.3%2.3 $8.66
8/31/20215,560,000 shares $43.81 million -22.5%7.9%2.3 $7.88
8/13/20217,170,000 shares $60.01 million +16.6%10.2%3.2 $8.37
7/30/20216,150,000 shares $48.65 million -41.8%9.3%3.2 $7.91
7/15/202110,560,000 shares $103.17 million -4.4%15.8%6.6 $9.77
6/30/202111,040,000 shares $120.23 million -11.3%16.5%7.5 $10.89
6/15/202112,450,000 shares $150.27 million -11.3%18.6%8.6 $12.07
5/28/202114,040,000 shares $202.32 million -2.8%21.0%8.5 $14.41
5/14/202114,440,000 shares $117.83 million +18.2%21.7%7.8 $8.16
4/30/202112,220,000 shares $149.94 million +5.8%17.7%6.5 $12.27
Elon’s AI venture could 10X (here’s how you could profit) (Ad)

What does Elon plan with all this computing power? Our research indicates he's gunning to take over the entire AI industry - which is projected to grow up to $23 TRILLION annually in the coming years... Elon's AI venture is already growing 7X faster than its main competitor, OpenAI. It could soon be the most powerful AI firm on the planet.

4/15/202111,550,000 shares $141.95 million +19.6%17.2%5 $12.29
3/31/20219,660,000 shares $121.91 million +71.9%14.6%4.3 $12.62
3/15/20215,620,000 shares $88.63 million +50.7%8.5%2.5 $15.77
2/26/20213,730,000 shares $56.02 million +43.5%5.7%2 $15.02
2/12/20212,600,000 shares $55.59 million +165.5%4.0%1.6 $21.38
1/29/2021979,200 shares $16.22 million +237.1%N/A0.8 $16.56
1/15/2021290,500 shares $6.83 million No ChangeN/A0.3 $23.50

HIMS Short Interest - Frequently Asked Questions

What is Hims & Hers Health's current short interest?

Short interest is the volume of Hims & Hers Health shares that have been sold short but have not yet been closed out or covered. As of January 15th, traders have sold 56,580,000 shares of HIMS short. 31.87% of Hims & Hers Health's shares are currently sold short. Learn More on Hims & Hers Health's current short interest.

What is a good short interest ratio for Hims & Hers Health?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HIMS shares currently have a short interest ratio of 4.0. Learn More on Hims & Hers Health's short interest ratio.

Which institutional investors are shorting Hims & Hers Health?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Hims & Hers Health: Belvedere Trading LLC, Apollon Wealth Management LLC, IMC Chicago LLC, Jane Street Group LLC, Wolverine Trading LLC, Walleye Trading LLC, Walleye Capital LLC, Crawford Fund Management LLC, and PEAK6 Investments LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Hims & Hers Health?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 31.87% of Hims & Hers Health's floating shares are currently sold short.

Is Hims & Hers Health's short interest increasing or decreasing?

Hims & Hers Health saw a increase in short interest in the month of January. As of January 15th, there was short interest totaling 56,580,000 shares, an increase of 8.6% from the previous total of 52,120,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Hims & Hers Health's float size?

Hims & Hers Health currently has issued a total of 218,480,000 shares. Some of Hims & Hers Health's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Hims & Hers Health currently has a public float of 177,520,000 shares.

How does Hims & Hers Health's short interest compare to its competitors?

31.87% of Hims & Hers Health's shares are currently sold short. Here is how the short interest of companies in the industry of "healthcare" compare to Hims & Hers Health: Natera, Inc. (3.21%), Fresenius Medical Care AG (0.14%), Guardant Health, Inc. (5.96%), Option Care Health, Inc. (2.54%), RadNet, Inc. (6.55%), BrightSpring Health Services, Inc. (15.29%), Sotera Health (4.52%), Veracyte, Inc. (3.94%), Surgery Partners, Inc. (14.28%), LifeStance Health Group, Inc. (8.61%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($4.18 billion), Charter Communications, Inc. ($3.91 billion), Reddit, Inc. ($3.16 billion), The Kroger Co. ($2.75 billion), International Paper ($2.57 billion), Cencora, Inc. ($2.06 billion), SoFi Technologies, Inc. ($2.06 billion), Rivian Automotive, Inc. ($2.00 billion), Live Nation Entertainment, Inc. ($1.63 billion), and Hims & Hers Health, Inc. ($1.57 billion). View all of the most shorted stocks.

What does it mean to sell short Hims & Hers Health stock?

Short selling HIMS is an investing strategy that aims to generate trading profit from Hims & Hers Health as its price is falling. HIMS shares are trading up $2.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Hims & Hers Health?

A short squeeze for Hims & Hers Health occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HIMS, which in turn drives the price of the stock up even further.

How often is Hims & Hers Health's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HIMS, twice per month. The most recent reporting period available is January, 15 2025.




This page (NYSE:HIMS) was last updated on 2/8/2025 by MarketBeat.com Staff
From Our Partners